14 Panel Urine Drug Test Dip Cards

Broad-Spectrum Urine Drug Screening in a Compact Dip Card Format

14 panel urine drug test dip cards are designed for expanded preliminary screening across multiple drug categories using a simple urine dip test format. These tests provide broader detection than smaller panel dip cards while remaining compact, easy to store, and simple to administer.

Different variations of our 14 panel urine drug test dip cards may screen for substances such as Alcohol / EtG, Amphetamines, Benzodiazepines, Buprenorphine, Cocaine, Ecstasy, Fentanyl, Gabapentin, K2, Marijuana, Methadone, Methamphetamine, Opiates, Oxycodone, PCP, and Barbiturates.

Because 14 panel dip card configurations can vary, always review the specific product description to confirm which substances are included on the test device before use.


What Is a 14 Panel Urine Drug Test Dip Card?

A 14 panel urine drug test dip card is a rapid screening device used to test a urine specimen for multiple drug classes or metabolites at the same time. The device is dipped directly into a urine sample, removed, placed on a flat surface, and read after the test develops.

Unlike a drug test cup, a dip card does not include a built-in specimen collection container. This makes dip cards a practical option when a separate collection container is already being used or when compact storage is preferred.

Most rapid urine drug test dip cards provide preliminary results within approximately 5 minutes.


Substances Available on 14 Panel Dip Card Configurations

Different 14 panel dip card options may include combinations of the following:

  • Alcohol / EtG

  • Amphetamines

  • Barbiturates

  • Benzodiazepines

  • Buprenorphine

  • Cocaine

  • Ecstasy / MDMA

  • Fentanyl

  • Gabapentin

  • K2 / Synthetic Cannabinoids

  • Marijuana / THC

  • Methadone

  • Methamphetamine

  • Opiates

  • Oxycodone

  • PCP

Not every 14 panel device will screen for the same exact substances. Always verify the listed analytes for the product being purchased.


Expanded Drug Categories in 14 Panel Dip Testing

Alcohol / EtG Testing

Some 14 panel dip cards include EtG, which is a metabolite of alcohol. EtG testing is used when a program needs to screen for recent alcohol consumption in addition to drug use.

Including EtG on a multi-panel dip card can reduce the need for a separate alcohol test in certain compliance-based testing programs.


Fentanyl Screening

Fentanyl is a synthetic opioid that may not be reliably detected by a standard opiate panel. Because of this, some 14 panel dip cards include a dedicated fentanyl test strip.

Fentanyl screening is especially important in forensic and compliance environments where synthetic opioid exposure may be a concern.


K2 / Synthetic Cannabinoid Screening

K2, sometimes referred to as synthetic marijuana or Spice, is chemically different from traditional marijuana. A standard THC test does not always detect synthetic cannabinoids.

A 14 panel dip card with K2 screening provides additional detection coverage for substances that may not appear on a traditional marijuana panel.


Gabapentin Testing

Some 14 panel configurations include gabapentin screening. Gabapentin is a prescription medication that may be monitored in certain forensic, institutional, or compliance-based testing programs.

Adding gabapentin to a multi-panel test provides broader prescription medication visibility than traditional drug panels.


Buprenorphine, Methadone, Oxycodone, and Opiates

A 14 panel urine drug test dip card may include several opioid-related test strips. These panels are often separated because different opioid categories may require dedicated screening.

Common opioid-related panels may include:

  • Buprenorphine

  • Methadone

  • Oxycodone

  • Opiates

This broader opioid coverage helps distinguish between different drug categories instead of relying on a single general opiate strip.


Amphetamines, Methamphetamine, Cocaine, and Ecstasy

Many 14 panel configurations include multiple stimulant-related panels, including Amphetamines, Methamphetamine, Cocaine, and Ecstasy / MDMA.

These panels help provide broader stimulant and recreational drug screening coverage in a single device.


Benzodiazepines, Barbiturates, and PCP

Some 14 panel dip cards include additional categories such as Benzodiazepines, Barbiturates, and PCP.

These substances may be included in expanded forensic or compliance-related testing panels when broader drug category coverage is required.


Why Choose a 14 Panel Urine Drug Test Dip Card?

A 14 panel urine drug test dip card is useful when a testing program requires expanded substance coverage but does not require an all-in-one cup format.

Key advantages include:

  • Screens for multiple drug classes in one device

  • Compact dip card format

  • Fast preliminary results

  • No electronic reader or analyzer required

  • Lower storage space than cup-based tests

  • Useful for broad preliminary screening

  • Multiple configurations available

  • Can include expanded analytes such as EtG, fentanyl, K2, and gabapentin

This makes 14 panel dip cards a strong option for programs that need broader testing coverage while keeping the process simple.


14 Panel Dip Cards vs. Smaller Panel Dip Cards

Smaller panel drug tests may only screen for a limited group of common substances. A 14 panel dip card provides broader detection by including additional prescription, synthetic, alcohol, and expanded drug categories.

Test Type General Purpose
5 Panel Dip Card Basic drug screening coverage
10 Panel Dip Card Expanded prescription and common drug screening
12 Panel Dip Card Broader multi-drug screening
14 Panel Dip Card Expanded coverage with additional specialty analytes
Single Panel Dip Card Targeted testing for one specific substance

A 14 panel dip card may be preferred when a program needs wider screening coverage without using multiple separate tests.


How to Use a 14 Panel Urine Drug Test Dip Card

Step 1: Collect the Urine Specimen

Collect the urine sample in a clean specimen container.

Step 2: Open the Test Device

Remove the 14 panel dip card from its sealed pouch immediately before testing.

Step 3: Dip the Card

Dip the absorbent end of the test card into the urine specimen according to the manufacturer’s instructions. Do not dip beyond the maximum line if one is indicated.

Step 4: Place the Test on a Flat Surface

Remove the card from the specimen and place it on a clean, level surface.

Step 5: Read the Results

Read results within the timeframe listed in the product instructions. Most rapid urine dip cards provide preliminary results within approximately 5 minutes.


How to Read 14 Panel Drug Test Dip Card Results

Negative Result

Two lines appear: one control line and one test line. This indicates the substance was not detected above the test cutoff level.

Preliminary Positive Result

Only the control line appears. No test line appears for the substance being screened. This indicates a preliminary positive result.

Invalid Result

No control line appears. The test should be considered invalid and repeated with a new device.

A faint test line is generally interpreted as negative as long as the control line is present and results are read within the proper timeframe.

All non-negative results should be confirmed through certified laboratory testing when required by policy, procedure, or legal standard.


Configuration Notice

14 panel urine drug test dip cards are not all the same. One version may include EtG and fentanyl, while another may include gabapentin, K2, barbiturates, or a different combination of analytes.

Before ordering or administering a test, confirm:

  • The exact substances included

  • The intended use designation

  • Whether the product is Forensic Use Only

  • Required confirmation procedures

  • Applicable program or agency requirements

This helps ensure the selected test matches the intended screening purpose.


Forensic Use Only Notice

Certain products may be labeled “Forensic Use Only” (FUO). These products are intended for professional forensic, institutional, law-enforcement-related, and compliance testing applications and are not intended to diagnose medical conditions or guide treatment decisions.


Frequently Asked Questions

What does a 14 panel urine drug test dip card screen for?

Different variations may screen for Alcohol / EtG, Amphetamines, Benzodiazepines, Buprenorphine, Cocaine, Ecstasy, Fentanyl, Gabapentin, K2, Marijuana, Methadone, Methamphetamine, Opiates, Oxycodone, PCP, and Barbiturates.

Are all 14 panel dip cards the same?

No. 14 panel configurations vary by product. Always review the specific product listing to confirm the substances included.

Does a 14 panel dip card detect fentanyl?

Some 14 panel configurations include fentanyl. Fentanyl must be specifically listed as one of the test panels.

Can a 14 panel dip card detect alcohol?

Some versions include EtG alcohol metabolite testing. If alcohol screening is required, confirm that EtG is listed on the product.

Does this type of test detect K2?

Certain 14 panel dip cards include K2 / synthetic cannabinoid screening. This is separate from standard THC testing.

Why are opiates, oxycodone, buprenorphine, and methadone listed separately?

These are different opioid-related testing categories. A standard opiate panel may not reliably detect all synthetic or semi-synthetic opioids, so dedicated strips may be included.

Does a 14 panel dip card require a collection cup?

A dip card requires a separate specimen collection container. It is not an all-in-one drug test cup.

How quickly are results available?

Most 14 panel urine drug test dip cards provide preliminary results within approximately 5 minutes.

What does a faint line mean?

A faint test line is generally considered negative as long as the control line is present and the test is read within the proper timeframe.

Are preliminary positive results final?

No. Dip cards provide preliminary screening results. Any non-negative result should be confirmed through certified laboratory testing when required.